scorecardresearch
Add as a preferred source on Google
Tuesday, April 7, 2026
TopicImdevimab

Topic: imdevimab

Effective against other variants, Regeneron antibody cocktail fails to tackle Omicron: Study

The study, primarily involving researchers from the Frankfurt-based Goethe University, has not yet been peer-reviewed. It has been shared on the preprint portal medRxiv.

On Camera

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

UAE walks away from financing Rafale F5 due to restricted access to technology, reports French media

French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.